Should a total or partial thyroidectomy be performed for a 10x8 mm papillary thyroid cancer nodule?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

For a small (10x8 mm) papillary thyroid cancer classified as TIRAD 4 nodule, active surveillance is recommended as the initial management approach, rather than immediate surgery, as it is safer and less costly, and helps in avoiding adverse events of surgery, as supported by recent studies 1. This approach is based on the fact that papillary thyroid microcarcinomas (PMCs) are defined as papillary thyroid carcinoma ≤10 mm, and active surveillance of PMC without high-risk features has been shown to be effective in managing low-risk PMCs, with most PMCs growing very slowly or not growing, and none of the patients showing distant metastasis or dying of thyroid carcinoma 1. The key factors to consider in this approach are:

  • The size of the tumor, which is 10x8 mm, making it a papillary microcarcinoma
  • The absence of high-risk features, such as clinical node metastasis, distant metastasis, and clinical evidence of significant extrathyroid extension
  • The patient's age, overall health status, family history, and patient preference, which should be discussed with the surgeon and endocrinologist to determine the best course of action As stated in the ESMO clinical practice guidelines for diagnosis, treatment, and follow-up of thyroid cancer, active US surveillance of the thyroid and neck lymph nodes (every 6–12 months) can be proposed for unifocal papillary microcarcinomas (10 mm) with no evidence of extracapsular extension or lymph node metastases 1. It is essential to note that the decision between active surveillance and surgery should be individualized based on specific patient factors, and regular monitoring with ultrasound and thyroid function tests should be expected if active surveillance is chosen.

From the Research

Surgical Approach for Papillary Thyroid Cancer

  • The decision to perform a total or partial thyroidectomy for a small tirad 4 nodule 10x8 mm papillary thyroid cancer depends on various factors, including the size of the tumor, presence of lymph node metastasis, and patient's overall health 2, 3.
  • A study published in the World Journal of Surgery in 2016 found that thyroid lobectomy is an effective surgical strategy to manage papillary microcarcinomas with low complications, and routine completion thyroidectomy is not mandatory 2.
  • However, another study published in Cancer Medicine in 2021 recommended that initial treatment should comprise at least total thyroidectomy + central lymph node dissection, particularly among patients with risk factors for poor prognosis 4.

Considerations for Surgical Approach

  • The size of the tumor is an important factor in determining the surgical approach, with larger tumors having a higher risk of lymph node metastasis 4.
  • The presence of lymph node metastasis is also a significant factor, with studies showing that the rate of neck lymph node metastasis is high, particularly among patients with risk factors for poor prognosis 4.
  • Patient selection is crucial, with appropriate selection excluding high-risk patients being of paramount importance in order to achieve the best results 2.

Alternative Management Options

  • Active surveillance has emerged as an alternative to operative management for low-risk papillary thyroid microcarcinoma without lymph node involvement or distant metastasis 5.
  • However, the decision to pursue active surveillance should be made on a case-by-case basis, taking into account the individual patient's risk factors and overall health 5.

Diagnostic Techniques

  • Innovative technologies, such as contrast-enhanced ultrasonography, frozen section, and molecular detection, have brought great progress to the diagnosis of small and indeterminate lymph nodes 6.
  • The implementation of these diagnostic techniques can help identify patients who are at higher risk of disease progression and metastasis, and guide the surgical approach accordingly 6.

Related Questions

What is the recommended surgical approach, partial thyroidectomy versus total thyroidectomy, and the need for radioactive iodine (RAI) therapy in a 25-year-old male with a single 10x8 mm right bilobed nodule, classified as TIRAD (Thyroid Imaging Reporting and Data System) 4, with no enlarged lymph nodes (LN), and a fine-needle aspiration (FNA) diagnosis of papillary thyroid cancer?
What is the clinical significance of a benign soft tissue mass and a stable 3 mm nodule in the fat anterior to the psoas muscle in a patient with a history of partial nephrectomy for chromophobe renal cell carcinoma?
What are the NCCN (National Comprehensive Cancer Network) guidelines for surveillance in a patient with stage PT1b papillary thyroid carcinoma and a history of ITP (Immune Thrombocytopenic Purpura)?
What are the treatment guidelines for thyroid cancer?
What is the optimal management approach for incidentally detected versus preoperatively diagnosed papillary thyroid microcarcinoma (PTMC)?
Can patients receiving Bacillus Calmette-Guérin (BCG) intravesical therapy experience hematuria?
Can patients receiving Bacillus Calmette-Guérin (BCG) intravesical therapy experience hematuria?
What anticoagulant is recommended for nonocclusive subsegmental pulmonary emboli (PE) in the distal segmental branches of the pulmonary arteries?
What causes decreased hemoglobin affinity to oxygen at the tissue level?
What is the significance of an elevated cell count in the peritoneal (peritoneal cavity) fluid?
What is the incidence of endometrial cancer after a Manchester (Mach) repair?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.